Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study

Journal of Infection and Chemotherapy - Tập 19 Số 1 - Trang 128-137 - 2013
Tetsuya Matsumoto1, Hideaki Hanaki2, Toshimi Kimura3, Manabu Nemoto4, Masaaki Higashihara5, Hiroyuki Yokota6, Shigeto Oda7, Nobu Akiyama8, Naoki Miyao9, Minoru Yoshida10, Tetsuo Yukioka11, Kazui Soma12, Kazuma Ohyashiki13, Yukio Suzuki14, Takao Arai15, Keiichi Ikegami16, Toshio Ichiwata17, Yoshihito Otsuka18, Masahiro Kobayashi19, Kyoichi Totsuka20, Keisuke Sunakawa21
1Department of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, 160-8402, Tokyo, Japan
2Research Center for Anti-infectious Drugs, Kitasato University, Tokyo, Japan
3Department of Pharmacy, Tokyo Women's Medical University Hospital, Tokyo, Japan
4Department of Emergency and Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan
5Department of Hematology, Internal Medicine, Kitasato University School of Medicine, Kanagawa, Japan
6Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
7Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
8Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
9Department of Pulmonary, Nippon Koukan Hospital, Kanagawa, Japan
10Fourth Department of Internal Medicine, Teikyo University School of Medicine Mizonokuchi Hospital, Kanagawa, Japan
11Department of Emergency and Critical Care Medicine, Tokyo Medical University, Tokyo, Japan
12Department of Emergency and Critical Care Medicine, Kitasato University School of Medicine, Kanagawa, Japan
13Division of Hematology, Tokyo Medical University, Tokyo, Japan
14Department of Respiratory Medicine, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan
15Trauma and Emergency Center Hachioji Medical Center of Tokyo Medical University, Tokyo, Japan
16Shock Trauma Center, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan
17Department of Respiratory Medicine, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
18Laboratory of Medicine, Kameda Medical Center, Chiba, Japan
19Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan
20Department of Infectious Diseases, Tokyo Women's Medical University, Tokyo, Japan
21Kitasato University Research Organization for Infection Control Sciences, Tokyo, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Totsuka, 1994, Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man, Jpn J Antibiot, 47, 676

Niijima, 1991, New antimicrobial agent series XL: arbekacin, Jpn J Antibiot, 44, 705

Meiji Seika Pharma Co., Ltd. Package insert of Habekacin® Injection, version 7, 2011.

Tanikaze, 2004, Study of clinical significance of PK/PD (pharmacokinetic/pharmacodynamic) parameters after administering arbekacin to patients with pulmonary methicillin-resistant Staphylococcus aureus infection, Jpn J Chemother, 52, 469

Aikawa, 2008, An open clinical study of arbekacin 200 mg q.d. in patients infected with methicillin-resistant Staphylococcus aureus (MRSA)—a clinical pharmacology study, Jpn J Chemother, 56, 299

Begg, 2001, The therapeutic monitoring of antimicrobial agents, Br J Clin Pharmacol, 52, 35S, 10.1046/j.1365-2125.2001.00377.x

Sawchuk, 1977, Kinetic model for gentamicin dosing with the use of individual patient parameters, Clin Pharmacol Ther, 21, 362, 10.1002/cpt1977213362

Demczar, 1997, Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing, Antimicrob Agents Chemother, 41, 1115, 10.1128/AAC.41.5.1115

Kobayashi, 2010, Therapeutic drug monitoring survey of anti-MRSA agents in Japan, Jpn J Chemother, 58, 119

Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580

Sato, 2010, Population pharmacokinetic analysis of arbekacin sulfate in adult patients, Jpn J Ther Drug Monit, 27, 98

Kimura, 2011, Dose finding study on arbekacin sulfate for appropriate peak levels, Jpn J Chemother, 59, 597

Ferreira, 2001, Serial evaluation of the SOFA score to predict outcome in critically ill patients, JAMA, 286, 1754, 10.1001/jama.286.14.1754

2008, 4

Kawano, 2010, Postmarketing surveillance review of arbekacin sulfate in patients with therapeutic drug monitoring, Jpn J Ther Drug Monit, 27, 55

Hwang, 2012, The usefulness of arbekacin compared to vancomycin, Eur J Clin Microbiol Infect Dis, 31, 1663, 10.1007/s10096-011-1490-9

Fowler, 2006, Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus, N Engl J Med, 355, 653, 10.1056/NEJMoa053783

Yamamoto, 2012, The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection, J Infect Chemother, 18, 241, 10.1007/s10156-012-0397-4

Thông tin
Thông tin xuất bản

Journal of Infection and Chemotherapy

Tập 19 Số 1

128-137

Thông tin tác giả